National survey of amblyopia treatment in Japan: comparison with amblyopia treatment study results of the pediatric eye disease investigator group
National survey of amblyopia treatment in Japan: comparison with amblyopia treatment study results of the pediatric eye disease investigator group
复制标题
日本弱视治疗全国调查：与小儿眼病调查组弱视治疗研究结果的比较
DOI：
10.1007/s10384-022-00968-3
复制
发表时间：
2022
影响因子：
2.4
通讯作者：
Nishina Sachiko
中科院分区：
文献类型：
--
作者：
Yoneda Tsuyoshi;Miki Atsushi;Wakayama Akemi;Nishina Sachiko
目的通过对多家机构的调查，了解截至2017年日本弱视的治疗政策，并与儿童眼病调查小组弱视治疗研究（ATS）的结果进行比较。研究设计：问卷调查研究。研究对象和方法向181个弱视患者接受治疗的机构发送问卷。将本调查结果与ATS研究结果进行比较，并评估其符合率。结果问卷回复率为68.0%。ATS研究结果与本研究结果最一致的治疗方案是是否对以前未接受过治疗的10-15岁患者进行治疗；90%的机构回答说，他们也会为这类患者提供治疗。其次是未来治疗弱视，患眼视力稳定；82.6%的机构回应会缩短遮挡时间。另一方面，一致性最低的是中度屈光参差性弱视的屈光矫正随访期。ATS的回答是“4个月”，而本次调查中大多数设施的回答是“3个月”。协议率为10.8%。结论日本弱视治疗调查结果与ATS的研究结果并不完全一致。日本眼科医生倾向于根据自己的临床经验制定弱视的治疗方案。
PurposeTo investigate the treatment policy for amblyopia in Japan as of 2017 through a survey of multiple facilities and to compare the findings with those obtained by the Amblyopia Treatment Study (ATS) of the Pediatric Eye Disease Investigator Group.Study designQuestionnaire survey study.Subjects and methodsA questionnaire was sent to 181 facilities where patients with amblyopia are being treated. The outcomes of the present survey were compared with the results of the ATS study, and the coincidence rates were evaluated.ResultsThe questionnaire response rate was 68.0%. The treatment plan that showed the highest agreement between the outcomes of the ATS study and the present study was whether or not treatment was to be given to patients aged 10–15 years who had received no previous treatment; 90% of the facilities answered that they would provide treatment to such patients as well. The next highest agreement was the future treatment of amblyopia with stable visual acuity in the affected eye; 82.6% of the facilities responded that they would reduce the occlusion time. On the other hand, the lowest agreement rate was the follow-up period of the refractive correction for moderate anisometropic amblyopia. The ATS showed “4 months,” whereas most of the facilities in the present survey replied “3 months.” The agreement rate was 10.8%.ConclusionThe amblyopia treatment in Japan survey did not always agree with the research results of the ATS. Japanese ophthalmologists tend to make treatment plans for amblyopia according to their clinical experience.